Pfizer-BioNTech COVID-19 vaccine gets FDA EUA for children, 12-15

On Monday, the Food and Drug Administration (FDA) announced that it has given Emergency Use Authorization (EUA) to PfizerBioNTech for their COVID-19 vaccine to be used to inoculate children in the age group of 12 to 15 years. Earlier, in December, the jab was available for 16 and above. This will increase the chances of reaching herd immunity much earlier plus it will also ease the return of children to school.


Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research released a statement along with the authorization. It stated that a vaccine was authorized for a younger population to continue to lessen the immense public health burden caused by the COVID-19 pandemic. He added that science guided their evaluations and decision-making procedures, and that the FDA could assure the public and medical community that the available data met their “rigorous standards to support the emergency use of this vaccine in the adolescent population 12 years of age and older.”


These vaccines will increase confidence in in-person activities in schools and can bring back some sense of normalcy. Children suffer less from the coronavirus and transmit it less easily. However, recent figures from the CDC show that children are getting infected in larger numbers.


America saw a four percent increase in those who tested positive among children between April 22 and May 6 and last week there were over 72,000 new cases of children who tested positive in the nation.


According to data from the American Pediatrics Association, child make up almost 24 percent of the new cases in the nation. Expanding vaccinations to this group can protect them as well as accelerate the vaccination rollout which is slowing down.


According to a Washington Post article almost 50 percent of schools have started full person learning by March 23. However, the CDC has stated that neither the teachers nor the students have to be vaccinated in order to return to schools. However, the Biden administration has prioritized the vaccination of teachers.

Follow us on Google news for more updates and News


This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer